Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1953 3
1954 4
1955 3
1956 2
1957 4
1958 5
1959 3
1960 3
1961 6
1962 10
1963 18
1964 12
1965 19
1966 20
1967 26
1968 23
1969 36
1970 19
1971 24
1972 28
1973 28
1974 32
1975 25
1976 21
1977 28
1978 27
1979 36
1980 26
1981 21
1982 43
1983 49
1984 54
1985 60
1986 57
1987 62
1988 90
1989 77
1990 87
1991 99
1992 104
1993 96
1994 104
1995 140
1996 134
1997 163
1998 162
1999 168
2000 176
2001 190
2002 192
2003 195
2004 188
2005 231
2006 208
2007 236
2008 256
2009 256
2010 279
2011 296
2012 303
2013 319
2014 362
2015 357
2016 349
2017 371
2018 421
2019 438
2020 419
2021 442
2022 464
2023 431
2024 405
2025 421
2026 378

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,788 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.
De Santis M, Palou Redorta J, Nishiyama H, Krawczyński M, Seyitkuliev A, Novikov A, Guerrero-Ramos F, Zukov R, Kato M, Kawahara T, Goeman L, Puente J, Hellmis E, Powles T, Radziszewski P, Gust KM, Vasey P, Bigot P, Fradet Y, Hunting J, Armstrong J, Boulos S, Hois S, Shore ND; POTOMAC Investigators. De Santis M, et al. Among authors: kato m. Lancet. 2025 Nov 8;406(10516):2221-2234. doi: 10.1016/S0140-6736(25)01897-5. Epub 2025 Oct 17. Lancet. 2025. PMID: 41115436 Clinical Trial.
Response.
Ando Y, Kato M, Ishihara R. Ando Y, et al. Among authors: kato m. Gastrointest Endosc. 2026 May;103(5):1097-1098. doi: 10.1016/j.gie.2025.11.018. Epub 2025 Dec 29. Gastrointest Endosc. 2026. PMID: 41460233 No abstract available.
Pharmacological treatment of schizophrenia: Japanese Expert Consensus 2025.
Takekita Y, Tani H, Kawamata Y, Katsuki A, Muraoka H, Ochi S, Tagata H, Sawada K, Nishi A, Hattori S, Kikuchi T, Baba H, Kato M, Watanabe K, Inada K, Yasui-Furukori N, Sakurai H, Iga JI. Takekita Y, et al. Among authors: kato m. Schizophrenia (Heidelb). 2026 Jun 2;12(1):70. doi: 10.1038/s41537-026-00770-x. Schizophrenia (Heidelb). 2026. PMID: 42230659 Free PMC article.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.
Maillard M, Schwab M, Whirl-Carrillo M, Moyer AM, Suarez-Kurtz G, Pui CH, Stein CM, Klein TE, Spahn C, Kwon S, Hartono JL, de Boer NK, Ahmad T, Antillon-Klussmann FG, Caudle KE, Kato M, Yeoh AEJ, Schmiegelow K, Yang JJ. Maillard M, et al. Among authors: kato m. Clin Pharmacol Ther. 2026 Apr;119(4):916-927. doi: 10.1002/cpt.70209. Epub 2026 Jan 31. Clin Pharmacol Ther. 2026. PMID: 41618934 Free PMC article.
Longitudinal single-cell analysis of glucagon-like peptide-2 treatment in patients with short bowel syndrome.
Kudo Y, Miyamoto K, Suzuki S, Chida A, Tojo A, Hasegawa M, Shigehara A, Koya I, Ando Y, Sato M, Kondo A, Kumagai T, Deguchi H, Sugiyama Y, Ito Y, Shirosaki K, Yamagishi S, Maeda Y, Kanamori H, Kano M, Kato M, Tsujikawa H, Yoshimatsu Y, Takabayashi K, Okabayashi K, Kanai T, Hosoe N, Kato M, Moody J, Hon CC, Kuroda T, Yamada Y, Fujino A, Sujino T. Kudo Y, et al. Among authors: kato m. JCI Insight. 2025 Aug 7;10(18):e194497. doi: 10.1172/jci.insight.194497. eCollection 2025 Sep 23. JCI Insight. 2025. PMID: 40773292 Free PMC article.
Right Ventricular Dysfunction in Lung Disease/Hypoxia-Associated Pulmonary Hypertension.
Shima H, Tsujino I, Nakaya T, Nakamura J, Igarashi-Sugimoto A, Sato T, Watanabe T, Ohira H, Hisada R, Kato M, Tsuneta S, Yokota I, Konno S. Shima H, et al. Among authors: kato m. J Am Heart Assoc. 2025 Aug 19;14(16):e042186. doi: 10.1161/JAHA.125.042186. Epub 2025 Aug 12. J Am Heart Assoc. 2025. PMID: 40792592 Free PMC article.
AKT5 is a bona fide potassium channel and controls petiole growth in Arabidopsis.
Muraoka Y, Kobayashi S, Oskam L, Tateyama M, Masago A, Tanaka Y, Yokoyama T, Furuta T, Takase H, Tanudjaja E, Terashima S, Shimizukawa H, Yamanashi T, Saito S, Ijima H, Tanaka M, Miyamoto A, Kato M, Sato K, Tsujii M, Umezawa T, Quintero FJ, Rubio F, Kudla J, Ito M, Kubo Y, Ishimaru Y, Pierik R, Uozumi N. Muraoka Y, et al. Among authors: kato m. Sci Adv. 2026 Sep 4;12(36):eaeh7630. doi: 10.1126/sciadv.aeh7630. Epub 2026 Sep 2. Sci Adv. 2026. PMID: 42685185 Free PMC article.
Genome sequencing provides high diagnostic yield and new etiological insights for intellectual disability and developmental delay.
Hamanaka K, Fujita A, Miyatake S, Misawa K, Koshimizu E, Uchiyama Y, Tsuchida N, Seyama R, Sakamoto M, Iwama K, Nishimura N, Utsuno Y, Fu L, Takizawa M, Liang Q, Itai T, Saida K, Ohori S, Kameyama S, Fukuda H, Hayashi Y, Inoue Y, Goto T, Ichikawa K, Kuki I, Fukuoka M, Kim K, Shiohama T, Shimoda K, Otsuka K, Ueda Y, Cho K, Yuge K, Tachi N, Yoshida M, Daida A, Hirasawa K, Yanagishita T, Yamamoto T, Shirai K, Mehr TF, Fattal-Valevski A, Lev D, Yokoyama H, Iwabuchi E, Saito Y, Miura M, Sugai K, Ishiyama A, Sasaki M, Watanabe Y, Takanashi JI, Kim CA, Yokochi K, Tohyama J, Mori T, Izumi Y, Hasegawa Y, Okamoto N, Ikeda T, Osaka H, Kawai Y, Omae Y, Tokunaga K, Kato M, Mizuguchi T, Matsumoto N. Hamanaka K, et al. Among authors: kato m. NPJ Genom Med. 2025 Aug 26;10(1):60. doi: 10.1038/s41525-025-00521-4. NPJ Genom Med. 2025. PMID: 40858643 Free PMC article.
CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting.
Itoh-Nakadai A, Liang M, Shindo M, Bibi C, Tomizawa-Murasawa M, Fujiki S, Kaneko A, Kanamaru E, Hashimoto M, Kajita H, Ando Y, Kojima M, Moody J, Iwasaki M, Takagi S, Nakagawa R, Agrawal S, Amitani-Iijima H, Sato K, Sorimachi Y, Suzuki N, Fukami T, Hanada K, Morita S, Katsura K, Matsumoto T, Kobayashi M, Kato M, Negishi Y, Shirouzu M, Najima Y, Takubo K, Hon CC, Uchida N, Taniguchi S, Momozawa Y, Carninci P, Shultz LD, Saito Y, de Hoon M, Shin JW, Ishikawa F. Itoh-Nakadai A, et al. Among authors: kato m. Nat Commun. 2026 Jan 26;17(1):101. doi: 10.1038/s41467-025-67745-x. Nat Commun. 2026. PMID: 41587986 Free PMC article.
9,788 results